from the most recent
ResMed Annual Report as filed on August 17, 2010):
sec.gov/Archives/edgar/data/943819/000119312510190619/d10k.htm. public companies are required by the SEC to report to their shareholders what they view as the most significant risks to their businesses. This is what ResMed says:
Our business depends on our ability to market effectively to dealers of home healthcare products and sleep clinics.
We market our products primarily to home healthcare dealers and to sleep clinics that diagnose OSA and other sleep disorders. We believe that home healthcare dealers and sleep clinics play a significant role in determining which brand of product a patient will use. The success of our business depends on our ability to market effectively to home healthcare dealers and sleep clinics to ensure that our products are properly marketed and sold by these third parties.
We have limited resources to market to approximately the 3,000 U.S. sleep clinics and the more than 6,000 home healthcare dealer branch locations, most of which use, sell or recommend several brands of products. In addition, home healthcare dealers have experienced price pressures as government and third-party reimbursement has declined for home healthcare products, and home healthcare dealers are requiring price discounts and longer periods of time to pay for products purchased from us. We cannot assure you that sleep clinic physicians will continue to prescribe our products, or that home healthcare dealers or patients will not substitute competing products when a prescription specifying our products has been written.
Tags:
-
▶ Reply to This